| 1 |
34779103 | Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin. | 2022 Mar |
1 |
| 2 |
34883184 | Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes. | 2022 Jan |
1 |
| 3 |
35169165 | Insulin clearance and incretin hormones following oral and "isoglycemic" intravenous glucose in type 2 diabetes patients under different antidiabetic treatments. | 2022 Feb 15 |
1 |
| 4 |
35395243 | Effects of insulin and sitagliptin on early cardiac dysfunction in diabetic rats. | 2022 Jun 15 |
1 |
| 5 |
35445591 | Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta-analysis. | 2022 Apr 20 |
2 |
| 6 |
35527084 | Corrigendum to "Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes" [Diabetes Res. Clin. Pract. 183 (2022) 109171]. | 2022 May 5 |
1 |
| 7 |
35547000 | Comparative Evaluation of Chiglitazar and Sitagliptin on the Levels of Retinol-Binding Protein 4 and Its Correlation With Insulin Resistance in Patients With Type 2 Diabetes. | 2022 |
1 |
| 8 |
35551683 | The effects of macronutrients composition on hormones and substrates during a meal tolerance test in drugnaive and sitagliptin-treated individuals with type 2 diabetes: a randomized crossover study. | 2022 May 12 |
1 |
| 9 |
33140566 | Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial. | 2021 Feb |
2 |
| 10 |
33241550 | Sitagliptin as an Initial Therapy and Differential Regulations of Metabolic Parameters Depending on its Glycemic Response in Subjects with Type 2 Diabetes. | 2021 Mar |
1 |
| 11 |
33258801 | Combined use of GABA and sitagliptin promotes human β-cell proliferation and reduces apoptosis. | 2021 Feb |
1 |
| 12 |
33464705 | An adult patient with permanent neonatal diabetes successfully discontinued insulin therapy after initiating sitagliptin added to sulphonylurea. | 2021 May |
1 |
| 13 |
34114012 | Letter to the Editor From Grill et al: "Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial". | 2021 Sep 27 |
1 |
| 14 |
34114619 | Response to the Letter to the Editor from Valdemar Grill et al: "Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial". | 2021 Sep 27 |
1 |
| 15 |
34406395 | Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance. | 2021 Aug 18 |
1 |
| 16 |
32095182 | Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes. | 2020 Feb |
2 |
| 17 |
32231757 | A Study of Seasonal Variation in the Effect of Add-On Sitagliptin on Blood Glucose Control in Insulin-Treated Patients With Type 2 Diabetes. | 2020 Mar |
2 |
| 18 |
32240122 | Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients. | 2020 Apr 2 |
3 |
| 19 |
32606870 | Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus. | 2020 |
5 |
| 20 |
32994187 | Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. | 2020 Dec |
1 |
| 21 |
33224612 | Evaluation of the use of sitagliptin for insulin resistance in burn patients. | 2020 |
7 |
| 22 |
30178570 | Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin. | 2019 Feb |
2 |
| 23 |
30393950 | Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study. | 2019 Apr |
3 |
| 24 |
30815579 | Progression of glucose-lowering diabetes therapy in TECOS. | 2019 Jan |
2 |
| 25 |
31019624 | Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study. | 2019 May |
3 |
| 26 |
31405334 | Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19. | 2019 Oct |
1 |
| 27 |
31543976 | Sitagliptin for the prevention of stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery. | 2019 |
1 |
| 28 |
28892258 | Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY. | 2018 Mar |
1 |
| 29 |
29138226 | Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge. | 2018 Apr 1 |
1 |
| 30 |
29208515 | Effectiveness of sitagliptin in a patient with late dumping syndrome after total gastrectomy. | 2018 Apr - Jun |
1 |
| 31 |
29227575 | Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects. | 2018 Apr |
1 |
| 32 |
29893003 | Comparative study of the effects of ipragliflozin and sitagliptin on multiple metabolic variables in Japanese patients with type 2 diabetes: A multicentre, randomized, prospective, open-label, active-controlled study. | 2018 Nov |
1 |
| 33 |
27087519 | Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study. | 2017 Feb |
2 |
| 34 |
27255431 | Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes. | 2017 May |
1 |
| 35 |
27740719 | Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes. | 2017 May |
2 |
| 36 |
28056430 | The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease. | 2017 Jan |
3 |
| 37 |
28213841 | Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial. | 2017 Jun |
4 |
| 38 |
28250768 | The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation. | 2017 |
2 |
| 39 |
28420697 | Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464. | 2017 Jun |
1 |
| 40 |
28516377 | The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis. | 2017 Jun |
2 |
| 41 |
28761576 | Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A Multicenter, Prospective Observational, Uncontrolled Study. | 2017 |
2 |
| 42 |
28829491 | The effect of sitagliptin on obese patients with insulin treatment-induced diabetes mellitus. | 2017 Aug |
3 |
| 43 |
28929327 | Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S). | 2017 Oct |
1 |
| 44 |
28933039 | Dose-Dependent Effect of Sitagliptin on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Post Hoc Analysis. | 2017 Oct |
2 |
| 45 |
28982699 | Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM). | 2017 Nov |
2 |
| 46 |
26822324 | Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial. | 2016 Mar |
2 |
| 47 |
27114254 | Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus. | 2016 Jun |
4 |
| 48 |
27222674 | Factor Analysis of Changes in Hemoglobin A1c After 12 Months of Sitagliptin Therapy in Patients With Type 2 Diabetes. | 2016 Jun |
1 |
| 49 |
27300579 | Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment. | 2016 Nov |
1 |
| 50 |
27321385 | Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus. | 2016 Aug 31 |
1 |